Activ8rlives News


Innovative company given a boost after awards success

Posted on July 20, 2016

Winning an award at The Hunts Post Huntingdonshire Business Awards is “a confidence boost”. That was the message from Aseptika Ltd (Activ8rlives) nine months after being crowned winners of the Innovation Award in 2015.

Managing director Kevin Auton said: “We were really excited particularly because of the very high standard of the other finalists – we were a bit surprised but it was really great to win.”

“There is definitely something about putting ourselves forward to be judged by our peers as the medical world is a bit niche so to be judged up against other companies is a real confidence boost.”

Winning the award has helped the firm work with a number of local suppliers and gain recognition throughout Huntingdonshire.

Dr Auton said: “Locally it has given us a huge boost, the engagement of the spot light has helped us with local suppliers as it is on the front of the presentation that we give.”

“The awareness of the company has been brilliant: it is the best advertising we could get.”

The company, based in Hartford was formed eight years ago by husband and wife team Jessica and Kevin Auton to enable everyone to have the tools to manage their own health and thereby live long and healthy lives and this hasn’t changed.

Aseptika Ltd (Activ8rlives) is still focused on its research and development of the BuddyWOTCH, which tracks blood oxygen saturation, heart rate, temperature, physical activity as well as monitoring the wearer’s overall health and wellbeing.

The firm has also gone on to receive more grants and has been selected to be involved with the Sheffield ‘Test Bed – Perfect Patient Pathway’ – that will allow for collaborations between NHS England and innovators to use technology to address issues facing patients with long-term respiratory conditions and the health service transformation of care pathways.

“Since the awards we have also started full engagement with patients with respiratory disease up in Liverpool (Knowsley Community COPD Service at the Liverpool Heart & Chest Hospital),” added Dr Auton.


Aseptika Ltd BuddyWOTCHTM in development for the use of self-care for patients with long-term respiratory or cardiovascular disease.


Tags: , , , , , ,


Latest Posts

Aseptika’s Asthma+me solution announced as Winner of Best Patient-Focused Technological Development in 2019 Clinical & Research Excellence Awards

Posted on May 7, 2019

Self-care: Councils helping people look after themselves

Posted on March 11, 2019

Asthma: Young people in the UK 'more likely to die'

Posted on February 20, 2019

Young people are at higher risk of having an asthma attack than any other age group living with the condition, the charity Asthma UK is warning

Posted on January 23, 2019

Aseptika wins grant from Innovate UK to undertake a clinical trial with its child asthma solution

Posted on January 21, 2019